ASCO GUIDELINES Bundle

Salivary Gland Hypofunction and or Xerostomia

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: http://eguideline.guidelinecentral.com/i/1475499

Contents of this Issue

Navigation

Page 1 of 5

Background ➤ Saliva plays a crucial role in the maintenance of tooth integrity, food and bacterial clearance, mechanical cleansing of the oral cavity, and oral comfort. Saliva also provides antimicrobial activity preventing oral infections and plays an important role in upper gastrointestinal functions including taste perception, formation of food bolus, facilitation of mastication, swallowing and speech, as well as lubrication of oropharyngeal and upper esophageal mucosa. Thus, salivary gland hypofunction is associated with an increased risk for oral infections, carious destruction of teeth, dysgeusia, oral mucosal discomfort, and a worsened nutritional state. ➤ Cancer patients may experience salivary gland hypofunction and xerostomia as a consequence of cancer therapy. This is most notable in head and neck cancer patients treated with external beam radiation therapy. In this setting, salivary gland hypofunction and xerostomia may be severe and permanent. This results in a profound, potentially life-long adverse impact on oral health and oral health-related quality of life. While radioactive iodine, total body irradiation, and high-dose chemotherapy with hematopoietic stem cell transplantation as well as moderate- dose chemotherapy for solid tumors may also cause salivary gland hypofunction, in these settings function loss and associated symptoms tend to be less severe and often less long-lasting.

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Salivary Gland Hypofunction and or Xerostomia